Jeffrey Zahn

This inventor holds 7 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 2 EPO patents. Top assignee: Rutgers, The State University of New Jersey. Active years: 2013-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeffrey Zahn. Retrieved from https://idiyas.com/inventor/jeffrey-zahn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 (Patent Applications = 1)

% Patents Active = 57.1

CIPO Patents = 2

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 3.5

ph-index = 2

Forward Citations = 8(Granted Patents)

Company Filing History:

7 out of 1,498

Rutgers, The State University of New Jersey

patents

Years Active: 2013-2025

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12508423 - Device for tissue electrotransfer using a microelectrode (2025-12-30),

2. 12508409 - System and method to use suction to enhance permeabilization and transfection of cells (2025-12-30),

3. 11987777 - High throughput, feedback-controlled electroporation microdevice for efficient molecular delivery into single cells (2024-05-21),

4. 10927333 - High throughput, feedback-controlled electroporation microdevice for efficient molecular delivery into single cells (2021-02-23),

5. 9383355 - Methods and related devices for continuous sensing utilizing magnetic beads (2016-07-05),

6. 8906702 - Methods and related devices for continuous sensing utilizing magnetic beads (2014-12-09),

7. 8615311 - Microelectorode array, methods for preparing the same and uses thereof (2013-12-24),

Title: Innovations by Jeffrey Zahn

Introduction

Jeffrey Zahn is a prominent inventor based in Princeton, NJ (US). He has made significant contributions to the field of molecular delivery systems, holding a total of 7 patents. His work focuses on developing advanced technologies for efficient molecular delivery into single cells.

Latest Patents

Among his latest patents is a high throughput, feedback-controlled electroporation microdevice designed for efficient molecular delivery into single cells. This innovative system utilizes intelligent, feedback-controlled microscale electroporation methods for transfecting single cells. The technology aims to enhance the precision and effectiveness of molecular delivery, which is crucial for various applications in biotechnology and medicine.

Career Highlights

Jeffrey Zahn is affiliated with Rutgers, The State University of New Jersey, where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on cellular biology and therapeutic applications.

Collaborations

Some of his notable coworkers include Lawrence Anthony Sasso, Jr. and Mingde Zheng, who contribute to the collaborative research environment at Rutgers.

Conclusion

Jeffrey Zahn's innovative work in the field of molecular delivery systems exemplifies the importance of advancements in biotechnology. His patents reflect a commitment to improving the efficiency of cellular transfection methods, paving the way for future breakthroughs in the field.

Profile summary based on public USPTO records.